INS and abnormal glucose tolerance: In the present study, pharmacotherapy (use of insulin or metformin) for management of hyperglycemia in pregnancy was strong predictor of progression to abnormal glucose tolerance at 6–12 weeks postpartum (OR 3.14; 95% CI; 1.20–8.21).